Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 17;10(5):1108.
doi: 10.3390/foods10051108.

Use of a Highly Antioxidant Diet in the Regulation of Adipose Tissue Secretion in Patients after the BIB Procedure

Affiliations

Use of a Highly Antioxidant Diet in the Regulation of Adipose Tissue Secretion in Patients after the BIB Procedure

Edyta Balejko et al. Foods. .

Abstract

Obesity is a global problem. The secretory activity of adipose tissue causes inflammation and disturbs metabolic parameters. Low-invasive bariatric procedures are an alternative to surgical treatment, especially in individuals who do not qualify for surgery or in whom conservative treatment does not bring the expected results. The diets designed for bariatric patients contained an increased proportion of bioflavonoids. The dietary components were carefully selected to provide anti-inflammatory effects. The experimental diets showed an antioxidant capacity (TEAC) of 433-969 µM TE/100 g or 100 mL, reducing ability (FRAP) of 13-58 µM TE/100 g or 100 mL, and total polyphenol content of 80-250 mg catechins/100 g or 100 mL. Lower levels of adipocytokines were obtained in the blood of patients following the diet. The results of the present study showed the participation of some adipocytokines in the regulation of energy homeostasis, lipid metabolism, glucose level, blood pressure and inflammation. Diet therapy should yield positive results in the long term, with the possibility of using immune modulation in personalized therapy for metabolic syndrome.

Keywords: 8-isoprostane; AGT; BIB (BioEnterics Intragastric Balloon); IL-1; IL-6; PAI-1; TNF-α; antioxidants; metabolic diseases; obesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Keaver L., Webber L., Dee A., Shiely F., Marsh T., Balanda K., Perry I.J. Application of the UK Foresight Obesity Model in Ireland: The Health and Economic Consequences of Projected Obesity Trends in Ireland. [(accessed on 13 March 2013)];2013 Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827424. - PMC - PubMed
    1. Manu P., Chandni R., Devarajan E.A. Study on Estimation of Visceral Fat and Its Metabolic and Clinical Correlates in Metabolic Syndrome. Clin. Proc. 2017;13:6–13.
    1. Allahverdi T.D. Obesity. IntechOpen; London, UK: 2020. Treatment Options in Morbid Obesity.
    1. Fernandez A.Z., Demaria E.J., Tichansky D.S., Kellum J.M., Wolfe L.G., Meador J., Sugerman H.J. Multivariate Analysis of Risk Factors for Death Following Gastric Bypass for Treatment of Morbid Obesity. Ann. Surg. 2004;239:698–703. doi: 10.1097/01.sla.0000124295.41578.ab. - DOI - PMC - PubMed
    1. Sjöström L., Gummesson A., Sjöström C.D., Narbro K., Peltonen M., Wedel H., Bengtsson C., Bouchard C., Carlsson B., Dahlgren S., et al. Swedish obese subjects study. Effects of bariatric surgery on mortality in swe-dish obese study. N. Engl. J. Med. 2007;8:741–752. doi: 10.1056/NEJMoa066254. - DOI - PubMed

LinkOut - more resources